198 related articles for article (PubMed ID: 36261538)
1. One-year supplementation with Lactobacillus reuteri ATCC PTA 6475 counteracts a degradation of gut microbiota in older women with low bone mineral density.
Li P; Ji B; Luo H; Sundh D; Lorentzon M; Nielsen J
NPJ Biofilms Microbiomes; 2022 Oct; 8(1):84. PubMed ID: 36261538
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Alterations in Older Women With Low Bone Mineral Density Supplemented With
Li P; Sundh D; Ji B; Lappa D; Ye L; Nielsen J; Lorentzon M
JBMR Plus; 2021 Apr; 5(4):e10478. PubMed ID: 33869994
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial.
Nilsson AG; Sundh D; Bäckhed F; Lorentzon M
J Intern Med; 2018 Sep; 284(3):307-317. PubMed ID: 29926979
[TBL] [Abstract][Full Text] [Related]
4. Limosilactobacillus reuteri 6475 and Prevention of Early Postmenopausal Bone Loss: A Randomized Clinical Trial.
Gregori G; Pivodic A; Magnusson P; Johansson L; Hjertonsson U; Brättemark E; Lorentzon M
JAMA Netw Open; 2024 Jun; 7(6):e2415455. PubMed ID: 38865129
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri derived from horse alleviates Escherichia coli-induced diarrhea by modulating gut microbiota.
Wang D; Zeng J; Wujin C; Ullah Q; Su Z
Microb Pathog; 2024 Mar; 188():106541. PubMed ID: 38224920
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
Mobini R; Tremaroli V; Ståhlman M; Karlsson F; Levin M; Ljungberg M; Sohlin M; Bertéus Forslund H; Perkins R; Bäckhed F; Jansson PA
Diabetes Obes Metab; 2017 Apr; 19(4):579-589. PubMed ID: 28009106
[TBL] [Abstract][Full Text] [Related]
8. Effects of
Martí M; Spreckels JE; Ranasinghe PD; Wejryd E; Marchini G; Sverremark-Ekström E; Jenmalm MC; Abrahamsson T
Cell Rep Med; 2021 Mar; 2(3):100206. PubMed ID: 33763652
[TBL] [Abstract][Full Text] [Related]
9. Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri.
Luo H; Li P; Wang H; Roos S; Ji B; Nielsen J
BMC Biotechnol; 2021 Jul; 21(1):46. PubMed ID: 34330235
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus reuteri attenuated allergic inflammation induced by HDM in the mouse and modulated gut microbes.
Li L; Fang Z; Liu X; Hu W; Lu W; Lee YK; Zhao J; Zhang H; Chen W
PLoS One; 2020; 15(4):e0231865. PubMed ID: 32315360
[TBL] [Abstract][Full Text] [Related]
11. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
[TBL] [Abstract][Full Text] [Related]
12. Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659.
Sendelius M; Axelsson J; Liu P; Roos S
J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37974056
[TBL] [Abstract][Full Text] [Related]
13. Effects of Lactobacillus acidophilus and L. reuteri on bone mass and gut microbiota in ovariectomized mice.
Chen J; Liu X; Li S; Li J; Fang G; Chen Y; Zhang X
Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):43-51. PubMed ID: 37807335
[TBL] [Abstract][Full Text] [Related]
14. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
[TBL] [Abstract][Full Text] [Related]
15. Ecological Importance of Cross-Feeding of the Intermediate Metabolite 1,2-Propanediol between Bacterial Gut Symbionts.
Cheng CC; Duar RM; Lin X; Perez-Munoz ME; Tollenaar S; Oh JH; van Pijkeren JP; Li F; van Sinderen D; Gänzle MG; Walter J
Appl Environ Microbiol; 2020 May; 86(11):. PubMed ID: 32276972
[TBL] [Abstract][Full Text] [Related]
16. Impact of Lactobacillus reuteri colonization on gut microbiota, inflammation, and crying time in infant colic.
Nation ML; Dunne EM; Joseph SJ; Mensah FK; Sung V; Satzke C; Tang MLK
Sci Rep; 2017 Nov; 7(1):15047. PubMed ID: 29118383
[TBL] [Abstract][Full Text] [Related]
17. In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
Gangaiah D; Mane SP; Tawari NR; Lakshmanan N; Ryan V; Volland A; Susanti D; Patel M; Abouzeid A; Helmes EB; Kumar A
PLoS One; 2022; 17(1):e0262663. PubMed ID: 35081129
[TBL] [Abstract][Full Text] [Related]
18. Probiotic Lactobacillus reuteri strains ATCC PTA 5289 and ATCC 55730 differ in their cariogenic properties in vitro.
Jalasvuori H; Haukioja A; Tenovuo J
Arch Oral Biol; 2012 Dec; 57(12):1633-8. PubMed ID: 23010217
[TBL] [Abstract][Full Text] [Related]
19. Gut Symbionts Lactobacillus reuteri R2lc and 2010 Encode a Polyketide Synthase Cluster That Activates the Mammalian Aryl Hydrocarbon Receptor.
Özçam M; Tocmo R; Oh JH; Afrazi A; Mezrich JD; Roos S; Claesen J; van Pijkeren JP
Appl Environ Microbiol; 2019 May; 85(10):. PubMed ID: 30389766
[TBL] [Abstract][Full Text] [Related]
20. Metagenomic Changes of Gut Microbiota following Treatment of
Dore MP; Sau R; Niolu C; Abbondio M; Tanca A; Bibbò S; Loria M; Pes GM; Uzzau S
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
